Kyle Mikson Analyst PerformanceManaging Director, Senior Research Analyst at Canaccord Genuity GroupKyle Mikson is a stock analyst at Canaccord Genuity Group in the healthcare sector, covering 21 publicly traded companies. Over the past year, Kyle Mikson has issued 72 stock ratings, including strong buy, buy, and hold recommendations. While full access to Kyle Mikson's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Kyle Mikson's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings108 Last 4 YearsBuy Recommendations68.00% 68 Buy RatingsCompanies Covered21 Unique Companies Ratings Distribution100RatingsDistribution of strong buy, buy, hold, and sell ratings by Kyle Mikson.RatingPercentageCount Strong Buy1.0%1 ratings Buy67.0%67 ratings Hold32.0%32 ratings Sell0.0%0 ratingsOut of 100 total stock ratings issued by Kyle Mikson at Canaccord Genuity Group, the majority (67.0%) have been Buy recommendations, followed by 32.0% Hold and 1.0% Strong Buy.Best & Worst CallsBest Call0000.0%BDSXMay 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%TTOOFeb 2022Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ100.0% of companies on NASDAQ21 companiesKyle Mikson, an analyst at Canaccord Genuity Group, currently covers 21 companies listed on , with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare21 companies100.0%Kyle Mikson of Canaccord Genuity Group specializes in stock coverage within the Healthcare sector.Coverage IndustriesIndustryPercentageLIFE SCIENCES TOOLS & SERVICES9 companies42.9%HEALTHCARE PROVIDERS & SERVICES6 companies28.6%BIOTECHNOLOGY5 companies23.8%HEALTHCARE EQUIPMENT & SUPPLIES1 company4.8% Kyle Mikson's Ratings History at Canaccord Genuity Group Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsNTRANatera8/7/2026Set Price Target$315.56$375.00$0.0000.00% ROIWGSGeneDx8/4/2026Boost Price Target$67.86$90.00Buy$0.0000.00% ROIVCYTVeracyte8/3/2026Lower Price Target$46.94$50.00Hold$0.0000.00% ROIILMNIllumina8/3/2026Boost Price Target$205.01$205.00Hold$0.0000.00% ROIVCYTVeracyte7/14/2026Boost Price Target$57.48$60.00Hold$0.0000.00% ROITXG10x Genomics7/14/2026Boost Price Target$41.77$50.00Buy$0.0000.00% ROITWSTTwist Bioscience7/14/2026Boost Price Target$90.35$120.00Buy$0.0000.00% ROINTRANatera7/14/2026Boost Price Target$272.89$330.00Buy$0.0000.00% ROIILMNIllumina7/14/2026Boost Price Target$190.05$190.00Hold$0.0000.00% ROIGHGuardant Health7/14/2026Boost Price Target$158.40$205.00Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. BDSXBiodesix6/18/2026Boost Price Target$16.09$27.00Buy$0.0000.00% ROITWSTTwist Bioscience6/15/2026Initiated Coverage$76.17$90.00Buy$0.0000.00% ROITWSTTwist Bioscience6/15/2026Initiated Coverage$80.79$90.00Buy$0.0000.00% ROIVCYTVeracyte5/6/2026Boost Price Target$37.62$42.00Hold$0.0000.00% ROIWGSGeneDx5/5/2026Set Price Target$67.93$75.00Buy$0.0000.00% ROIBDSXBiodesix5/5/2026Boost Price Target$14.78$22.00Buy$0.0000.00% ROISEERSeer5/4/2026Initiated Coverage$2.03$4.00Buy$0.0000.00% ROISEERSeer5/4/2026Upgrade$1.86$4.00Strong-Buy$0.0000.00% ROIILMNIllumina5/1/2026Lower Price Target$126.74$140.00Hold$0.0000.00% ROIXGNExagen4/20/2026Lower Price Target$2.96$8.00Buy$0.0000.00% ROIWGSGeneDx4/20/2026Set Price Target$68.51$100.00Buy$0.0000.00% ROIRGENRepligen4/20/2026Lower Price Target$132.53$145.00Hold$0.0000.00% ROIQTRXQuanterix4/20/2026Lower Price Target$3.43$4.00Hold$0.0000.00% ROICSTLCastle Biosciences4/20/2026Lower Price Target$25.21$40.00Buy$0.0000.00% ROIVCYTVeracyte4/20/2026Lower Price Target$33.40$40.00Hold$0.0000.00% ROITXG10x Genomics4/20/2026Boost Price Target$25.25$32.00Buy$0.0000.00% ROICAICaris Life Sciences3/13/2026Lower Price Target$18.10$22.00Hold$0.0000.00% ROIXGNExagen3/11/2026Lower Price Target$3.08$10.00Buy$0.0000.00% ROIQSIQuantum-Si3/4/2026Lower Price Target$0.93$1.00Hold$0.0000.00% ROIGRALGRAIL2/20/2026Lower Price Target$101.53$80.00Buy$0.0000.00% ROIGHGuardant Health2/20/2026Boost Price Target$106.38$135.00Buy$0.0000.00% ROIBDSXBiodesix2/17/2026Reiterated Rating$11.11$20.00Buy$0.0000.00% ROITXG10x Genomics2/13/2026Set Price Target$17.51$22.00$0.0000.00% ROIILMNIllumina1/26/2026Boost Price Target$150.28$150.00Hold$0.0000.00% ROINTRANatera1/12/2026Reiterated Rating$234.31Buy$0.0000.00% ROICAICaris Life Sciences12/22/2025Boost Price Target$27.94$30.00Hold$0.0000.00% ROITXG10x Genomics12/22/2025Boost Price Target$16.05$20.00Buy$0.0000.00% ROITEMTempus AI12/22/2025Lower Price Target$64.46$80.00Buy$0.0000.00% ROIQTRXQuanterix12/22/2025Boost Price Target$6.59$8.00Hold$0.0000.00% ROIQSIQuantum-Si12/22/2025Lower Price Target$1.27$1.50Hold$0.0000.00% ROISmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid (Ad)A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from collapsing — and billionaire Sam Altman is now an investor. This under-the-radar firm is drawing serious attention from those watching the energy infrastructure space closely.Click here to learn this company's name for free todayNTRANatera12/22/2025Boost Price Target$231.96$285.00Buy$0.0000.00% ROIILMNIllumina12/22/2025Boost Price Target$134.78$130.00Hold$0.0000.00% ROIGHGuardant Health12/22/2025Boost Price Target$99.74$125.00Buy$0.0000.00% ROICSTLCastle Biosciences12/22/2025Boost Price Target$39.44$50.00Buy$0.0000.00% ROIWGSGeneDx12/22/2025Boost Price Target$140.44$170.00Buy$0.0000.00% ROINTRANatera12/8/2025Reiterated Rating$241.17$250.00Buy$0.0000.00% ROICAICaris Life Sciences12/2/2025Initiated Coverage$28.86$28.00Hold$0.0000.00% ROIEXASExact Sciences11/25/2025Downgrade$101.01$105.00Hold$0.0000.00% ROIGRALGRAIL11/17/2025Boost Price Target$79.63$105.00Buy$0.0000.00% ROINTRANatera11/7/2025Boost Price Target$199.57$250.00Buy$0.0000.00% ROITXG10x Genomics11/7/2025Boost Price Target$15.25$19.00Buy$0.0000.00% ROIVCYTVeracyte11/5/2025Boost Price Target$36.12$43.00Hold$0.0000.00% ROITEMTempus AI11/5/2025Lower Price Target$84.49$95.00Buy$0.0000.00% ROIILMNIllumina10/31/2025Boost Price Target$99.01$112.00Hold$0.0000.00% ROIGHGuardant Health10/30/2025Set Price Target$72.27$100.00$0.0000.00% ROIGHGuardant Health10/30/2025Boost Price Target$72.27$100.00Buy$0.0000.00% ROIWGSGeneDx10/29/2025Set Price Target$140.19$160.00Buy$0.0000.00% ROIRGENRepligen10/29/2025Boost Price Target$152.85$165.00Hold$0.0000.00% ROIXGNExagen10/27/2025Boost Price Target$11.96$15.00Buy$0.0000.00% ROIQSIQuantum-Si10/27/2025Boost Price Target$2.29$2.00Hold$0.0000.00% ROIGRALGRAIL10/22/2025Boost Price Target$81.33$85.00Buy$0.0000.00% ROIWGSGeneDx10/20/2025Set Price Target$120.94$155.00Buy$0.0000.00% ROIVCYTVeracyte10/20/2025Initiated Coverage$35.83$40.00Hold$0.0000.00% ROITEMTempus AI10/20/2025Initiated Coverage$87.78$110.00Buy$0.0000.00% ROINTRANatera10/14/2025Reiterated Rating$172.81$200.00Buy$0.0000.00% ROIGRALGRAIL10/3/2025Boost Price Target$72.37$75.00Buy$0.0000.00% ROIGHGuardant Health9/26/2025Boost Price Target$60.18$75.00Buy$0.0000.00% ROIBDSXBiodesix9/19/2025Set Price Target$6.77$20.00Buy$0.0000.00% ROIQSIQuantum-Si9/9/2025Reiterated Rating$1.08$1.00Hold$0.0000.00% ROICSTLCastle Biosciences9/9/2025Reiterated Rating$24.05$37.00Buy$0.0000.00% ROITXG10x Genomics8/11/2025Set Price Target$12.41$16.00$0.0000.00% ROIQTRXQuanterix8/11/2025Reiterated Rating$4.75$5.00Hold$0.0000.00% ROIILMNIllumina8/1/2025Boost Price Target$96.17$105.00Hold$000.0000.00% ROIXGNExagen7/30/2025Boost Price Target$8.45$11.00Buy$0.0000.00% ROIILMNIllumina6/11/2025Boost Price Target$87.98$99.00Hold$000.0000.00% ROIBDSXBiodesix5/14/2025Lower Price Target$4.40$30.00Buy$00.0000.00% ROIXGNExagen5/13/2025Boost Price Target$5.48$8.00Buy$0.0000.00% ROIQTRXQuanterix5/13/2025Lower Price Target$4.75$12.00Buy$0.0000.00% ROIILMNIllumina5/12/2025Lower Price Target$75.76$87.00Hold$000.0000.00% ROITXG10x Genomics5/12/2025Lower Price Target$9.44$15.00Buy$00.0000.00% ROICSTLCastle Biosciences5/6/2025Lower Price Target$18.75$37.00Buy$00.0000.00% ROIGHGuardant Health5/1/2025Boost Price Target$48.89$65.00Buy$00.0000.00% ROIILMNIllumina4/29/2025Lower Price Target$77.22$92.00Hold$000.0000.00% ROIBDSXBiodesix4/29/2025Lower Price Target$11.40$50.00Buy$0.0000.00% ROIGRALGRAIL4/21/2025Initiated Coverage$27.00$32.00Buy$00.0000.00% ROIPACBPacific Biosciences of California4/10/2025Reiterated Rating$1.38$3.00Buy$0.0000.00% ROIQTRXQuanterix3/18/2025Lower Price Target$7.28$15.00Buy$0.0000.00% ROIILMNIllumina3/11/2025Lower Price Target$85.97$115.00Hold$000.0000.00% ROINTRANatera2/26/2025Reiterated Rating$161.43$180.00Buy$000.0000.00% ROIGHGuardant Health2/24/2025Boost Price Target$42.87$60.00Buy$00.0000.00% ROIThe $15 Gold Fund That Pays Up to $1,152/Month (Ad)Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying out up to $1,152 a month to regular investors - no mining stocks, no options, no physical metal required. Chief Income Strategist Tim Plaehn calls it a breakthrough strategy that transforms gold's rally into reliable monthly payouts. The next distribution is just days away.Discover the gold income fund before the next payout dateTXG10x Genomics2/13/2025Lower Price Target$11.94$18.00Buy$00.0000.00% ROIILMNIllumina2/7/2025Lower Price Target$112.34$135.00Hold$000.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerDeutsche Bank AktiengesellschaftBMO Capital Markets Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
